These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 24096287)

  • 21. [Clinical outcome of patients with follicular development retardation by prolonged duration of gonadotropin administration for in vitro fertilization].
    Chen SL; Sun L; Kong LH; Li L; Li J; Zhu L; Gao TM; Xing FQ
    Zhonghua Fu Chan Ke Za Zhi; 2007 Aug; 42(8):526-9. PubMed ID: 17983490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Luteal phase ovarian stimulation following oocyte retrieval: is it helpful for poor responders?
    Zhang J
    Reprod Biol Endocrinol; 2015 Jul; 13():76. PubMed ID: 26209449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myo-inositol therapy for poor-responders during IVF: a prospective controlled observational trial.
    Caprio F; D'Eufemia MD; Trotta C; Campitiello MR; Ianniello R; Mele D; Colacurci N
    J Ovarian Res; 2015 Jun; 8():37. PubMed ID: 26067283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does daily co-administration of letrozole and gonadotropins during ovarian stimulation improve IVF outcome?
    Haas J; Bassil R; Meriano J; Samara N; Barzilay E; Gonen N; Casper RF
    Reprod Biol Endocrinol; 2017 Aug; 15(1):70. PubMed ID: 28854933
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro fertilization versus conversion to intrauterine insemination in the setting of three or fewer follicles: how should patients proceed when follicular response falls short of expectation?
    Reichman DE; Gunnala V; Meyer L; Spandorfer S; Schattman G; Davis OK; Rosenwaks Z
    Fertil Steril; 2013 Jul; 100(1):94-9. PubMed ID: 23615126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Poor responders in IVF: cancellation of a first cycle is not predictive of a subsequent failure.
    Baka S; Makrakis E; Tzanakaki D; Konidaris S; Hassiakos D; Moustakarias T; Creatsas G
    Ann N Y Acad Sci; 2006 Dec; 1092():418-25. PubMed ID: 17308168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. What is new in the management of poor ovarian response in IVF?
    Vaiarelli A; Cimadomo D; Ubaldi N; Rienzi L; Ubaldi FM
    Curr Opin Obstet Gynecol; 2018 Jun; 30(3):155-162. PubMed ID: 29664789
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparisons of GnRH antagonist versus GnRH agonist protocol in poor ovarian responders undergoing IVF.
    Pu D; Wu J; Liu J
    Hum Reprod; 2011 Oct; 26(10):2742-9. PubMed ID: 21778283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomised controlled trial of 300 versus 225 IU recombinant FSH for ovarian stimulation in predicted normal responders by antral follicle count.
    Jayaprakasan K; Hopkisson J; Campbell B; Johnson I; Thornton J; Raine-Fenning N
    BJOG; 2010 Jun; 117(7):853-62. PubMed ID: 20353458
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum progesterone level effects on the outcome of in vitro fertilization in patients with different ovarian response: an analysis of more than 10,000 cycles.
    Xu B; Li Z; Zhang H; Jin L; Li Y; Ai J; Zhu G
    Fertil Steril; 2012 Jun; 97(6):1321-7.e1-4. PubMed ID: 22494924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of prolonging administration gonadotropin on unexpectedly poor ovarian responders undergoing in vitro fertilization.
    Wei Z; Cheng X; Li H; Cao Y; Cong L; Zhou P; Li J
    Reprod Biol Endocrinol; 2010 Mar; 8():26. PubMed ID: 20236519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does metformin affect the ovarian response to gonadotropins for in vitro fertilization treatment in patients with polycystic ovary syndrome and reduced ovarian reserve? A randomized controlled trial.
    Palomba S; Falbo A; Di Cello A; Cappiello F; Tolino A; Zullo F
    Fertil Steril; 2011 Nov; 96(5):1128-33. PubMed ID: 21917254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Follicular flushing and in vitro fertilization outcomes in the poorest responders: a randomized controlled trial.
    Mok-Lin E; Brauer AA; Schattman G; Zaninovic N; Rosenwaks Z; Spandorfer S
    Hum Reprod; 2013 Nov; 28(11):2990-5. PubMed ID: 24014603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of gonadotropin-releasing hormone (GnRH) antagonist and GnRH agonist flare protocols for poor responders undergoing in vitro fertilization.
    Berin I; Stein DE; Keltz MD
    Fertil Steril; 2010 Feb; 93(2):360-3. PubMed ID: 19131055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The cumulative dose of gonadotropins used for controlled ovarian stimulation does not influence the odds of embryonic aneuploidy in patients with normal ovarian response.
    Sekhon L; Shaia K; Santistevan A; Cohn KH; Lee JA; Beim PY; Copperman AB
    J Assist Reprod Genet; 2017 Jun; 34(6):749-758. PubMed ID: 28321529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multi-marker assessment of ovarian reserve predicts oocyte yield after ovulation induction.
    Al-Azemi M; Killick SR; Duffy S; Pye C; Refaat B; Hill N; Ledger W
    Hum Reprod; 2011 Feb; 26(2):414-22. PubMed ID: 21147822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of anti-Müllerian hormone and antral follicle count to predict the potential of oocytes and embryos.
    Majumder K; Gelbaya TA; Laing I; Nardo LG
    Eur J Obstet Gynecol Reprod Biol; 2010 Jun; 150(2):166-70. PubMed ID: 20223579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Follitropin-alpha (Gonal-F) versus follitropin-beta (Puregon) in controlled ovarian hyperstimulation for in vitro fertilization: is there any difference?
    Orvieto R; Nahum R; Rabinson J; Ashkenazi J; Anteby EY; Meltcer S
    Fertil Steril; 2009 Apr; 91(4 Suppl):1522-5. PubMed ID: 18851846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Which ovarian stimulation parameters influence the number and proportion of mature oocytes retrieved in IVF cycles?
    Sethi A; Singh N; Patel G
    J Assist Reprod Genet; 2021 Nov; 38(11):3061-3062. PubMed ID: 34623543
    [No Abstract]   [Full Text] [Related]  

  • 40. Androgen pretreatment in poor responders undergoing controlled ovarian stimulation and in vitro fertilization treatment.
    Sunkara SK; Coomarasamy A
    Fertil Steril; 2011 Jun; 95(8):e73-4; author reply e75. PubMed ID: 21601849
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.